Your browser doesn't support javascript.
loading
Comparative efficacies of various corticosteroids for preventing postextubation stridor and reintubation: a systematic review and network meta-analysis.
Feng, I-Jung; Lin, Jia-Wei; Lai, Chih-Cheng; Cheng, Kuo-Chen; Chen, Chin-Ming; Chao, Chien-Ming; Wang, Ying-Ting; Chiang, Shyh-Ren; Liao, Kuang-Ming.
Afiliação
  • Feng IJ; Institute of Precision Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
  • Lin JW; Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan.
  • Lai CC; Division of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
  • Cheng KC; Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
  • Chen CM; Department of Safety, Health, and Environmental Engineering, Chung Hwa University of Medical Technology, Tainan, Taiwan.
  • Chao CM; Departments of Intensive Care Medicine, Chi Mei Medical Center, Tainan, Taiwan.
  • Wang YT; Recreation and Health-Care Management, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.
  • Chiang SR; Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Taiwan.
  • Liao KM; Departments of Respiratory Therapy, Chi Mei Medical Center, Tainan, Taiwan.
Front Med (Lausanne) ; 10: 1135570, 2023.
Article em En | MEDLINE | ID: mdl-37554508
ABSTRACT

Objectives:

We assessed the efficacies of various corticosteroid treatments for preventing postexubation stridor and reintubation in mechanically ventilated adults with planned extubation.

Methods:

We searched the Pubmed, Embase, the Cochrane databases and ClinicalTrial.gov registration for articles published through September 29, 2022. Only randomized controlled trials (RCTs) that compared the clinical efficacies of systemic corticosteroids and other therapeutics for preventing postextubation stridor and reintubation were included. The primary outcome was postextubation stridor and the secondary outcome was reintubation.

Results:

The 11 assessed RCTs reported 4 nodes methylprednisolone, dexamethasone, hydrocortisone, and placebo, which yielded 3 possible pairs for comparing the risks of post extubation stridor and 3 possible pairs for comparing the risks of reintubation. The risk of postextubation stridor was significantly lower in dexamethasone- and methylprednisolone-treated patients than in placebo-treated patients (dexamethasone OR = 0.39; 95% CI = 0.22-0.70; methylprednisolone OR = 0.22; 95% CI = 0.11-0.41). The risk of postextubation stridor was significantly lower in methylprednisolone-treated patients than in hydrocortisone-treated OR = 0.24; 95% CI = 0.08-0.67) and dexamethasone-treated patients OR = 0.55; 95% CI = 0.24-1.26). The risk of reintubation was significantly lower in dexamethasone- and methylprednisolone-treated patients than in placebo-treated patients (dexamethasone OR = 0.34; 95% CI = 0.13-0.85; methylprednisolone OR = 0.42; 95% CI = 0.25-0.70). Cluster analysis showed that dexamethasone- and methylprednisolone-treated patients had the lowest risks of stridor and reintubation. Subgroup analyses of patients with positive cuff-leak tests showed similar results.

Conclusions:

Methylprednisolone and dexamethasone were the most effective agents against postextubation stridor and reintubation.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan